Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianguo Tao

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Blood|February 17, 2018
BRD4: epigenetic origin and target of CTCLXiaohong Zhao, Jianguo Tao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosisJianguo Tao, Keith Flaherty, Adam Bagg
Cell Cycle (Georgetown, Tex.)|January 8, 2014
c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignanciesJiangchuan Tao, Xiaohong Zhao, Jianguo Tao
Journal of Hematopathology|October 29, 2024
Concurrent involvement of the bone marrow by BRAF V600E-mutant melanoma and hairy cell leukemiaMargaret Moore, Pranav Patel, Jianguo Tao
Oncotarget|December 10, 2013
MYC and MiR: vicious circleXiaohong Zhao, Xinwei Zhang, Jianguo Tao
Oncotarget|November 24, 2012
Epigenetics, c-Myc and aggressive B-cell lymphomasYizhuo Zhang, Xiaohong Zhao, Jianguo Tao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Merkel cell carcinoma in the peripheral blood of a patient with concomitant chronic lymphocytic leukemia and multiple myelomaMonique A Hartley, Jianguo Tao, Rachid Baz
American Journal of Hematology|January 6, 2007
Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literatureTodd J Alekshun, Jianguo Tao, Lubomir Sokol
Trends in Cancer|January 8, 2026
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomasJianguo Tao, Kevin Qiu, Michael E Williams
Cancers|October 16, 2025
Transcriptional Condensates: Epigenetic Reprogramming and Therapeutic Targets in Hematologic MalignanciesKevin Qiu, Qing Yin, Chongzhi Zang, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Blood|February 17, 2018
BRD4: epigenetic origin and target of CTCLXiaohong Zhao, Jianguo Tao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosisJianguo Tao, Keith Flaherty, Adam Bagg
Cell Cycle (Georgetown, Tex.)|January 8, 2014
c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignanciesJiangchuan Tao, Xiaohong Zhao, Jianguo Tao
Journal of Hematopathology|October 29, 2024
Concurrent involvement of the bone marrow by BRAF V600E-mutant melanoma and hairy cell leukemiaMargaret Moore, Pranav Patel, Jianguo Tao
Oncotarget|December 10, 2013
MYC and MiR: vicious circleXiaohong Zhao, Xinwei Zhang, Jianguo Tao
Oncotarget|November 24, 2012
Epigenetics, c-Myc and aggressive B-cell lymphomasYizhuo Zhang, Xiaohong Zhao, Jianguo Tao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Merkel cell carcinoma in the peripheral blood of a patient with concomitant chronic lymphocytic leukemia and multiple myelomaMonique A Hartley, Jianguo Tao, Rachid Baz
American Journal of Hematology|January 6, 2007
Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literatureTodd J Alekshun, Jianguo Tao, Lubomir Sokol
Trends in Cancer|January 8, 2026
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomasJianguo Tao, Kevin Qiu, Michael E Williams
Cancers|October 16, 2025
Transcriptional Condensates: Epigenetic Reprogramming and Therapeutic Targets in Hematologic MalignanciesKevin Qiu, Qing Yin, Chongzhi Zang, et al.
Pageof 8